Persistent complete molecular remission after nilotinib and graft-versus-leukemia effect in an acute lymphoblastic leukemia patient with cytogenetic relapse after allogeneic stem cell transplantation

Bibliographic Details
Title: Persistent complete molecular remission after nilotinib and graft-versus-leukemia effect in an acute lymphoblastic leukemia patient with cytogenetic relapse after allogeneic stem cell transplantation
Authors: Farnsworth Paul, Ward David, Reddy Vijay
Source: Experimental Hematology & Oncology, Vol 1, Iss 1, p 29 (2012)
Publisher Information: BMC, 2012.
Publication Year: 2012
Collection: LCC:Diseases of the blood and blood-forming organs
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Philadelphia chromosome positive acute lymphoblastic leukemia (PH + ALL), Nilotinib, Extracorporeal photopheresis (ECP), Graft-versus-host disease (GVHD), Graft-versus-leukemia effect (GVL), Hematopoietic stem cell transplantation (HSCT), Diseases of the blood and blood-forming organs, RC633-647.5, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Abstract We report the successful treatment and sustained molecular remission using single agent nilotinib in a relapsed Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia patient after allogeneic hematopoietic stem cell transplantation. Compared to previously published studies, this is the first report where a patient did not receive additional chemotherapy after relapse, nor did she receive donor lymphocyte infusions. With nilotinib, the patient reverted back to normal blood counts and 100% donor reconstitution by single tandem repeat (STR) chimerism analysis in the bone marrow and in peripheral blood, granulocytes, T and B-lymphocytes. This report also highlights the use of nilotinib in combination with extracorporeal photopheresis (ECP) for concomitant graft-versus-host disease. Our data suggests that ECP, together with nilotinib, did not adversely affect the overall Graft-versus-leukemia (GVL) effect.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2162-3619
Relation: http://www.ehoonline.org/content/1/1/29; https://doaj.org/toc/2162-3619
DOI: 10.1186/2162-3619-1-29
Access URL: https://doaj.org/article/6d319e38146d404eae5a3e8b6329f71e
Accession Number: edsdoj.6d319e38146d404eae5a3e8b6329f71e
Database: Directory of Open Access Journals
More Details
ISSN:21623619
DOI:10.1186/2162-3619-1-29
Published in:Experimental Hematology & Oncology
Language:English